Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Oct;58(10):1114-1123.
doi: 10.1007/s00108-017-0308-y.

[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]

[Article in German]
M Koziolek  1 , J Beige  2   3 , M Wallbach  4 , D Zenker  5 , G Henning  6 , M Halbach  7 , N Mader  8 , F Mahfoud  9   10 , G Schlieper  11 , V Schwenger  12 , M Hausberg  13 , J Börgel  14 , M Lodde  14 , M van der Giet  15 , J Müller-Ehmsen  16 , J Passauer  17 , S Parmentier  17 , S Lüders  18 , B K Krämer  19 , S Büttner  20 , F Limbourg  21 , J Jordan  22 , O Vonend  23 , H-G Predel  24 , H Reuter  7
Affiliations
Comparative Study

[Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection : Recommendations of the BAT consensus group 2017]

[Article in German]
M Koziolek et al. Internist (Berl). 2017 Oct.

Abstract

Baroreceptor activation therapy (BAT) has been available for several years for treatment of therapy-refractory hypertension (trHTN). This procedure is currently being carried out in a limited number of centers in Germany, also with the aim of offering a high level of expertise through sufficient experience; however, a growing number of patients who are treated with BAT experience problems that treating physicians are confronted with in routine medical practice. In order to address these problems, a consensus conference was held with experts in the field of trHTN in November 2016, which summarizes the current evidence and experience as well as the problem areas in handling BAT patients.

Keywords: Baroreflex; Blood pressure decrease; Efficacy; Organoprotection; Safety.

PubMed Disclaimer

References

    1. Hypertension. 2009 Sep;54(3):530-6 - PubMed
    1. J Hypertens. 2016 Aug;34(8):1630-8 - PubMed
    1. Hypertension. 2013 Jun;61(6):1334-9 - PubMed
    1. J Hypertens. 2015 Nov;33(11):2344-9 - PubMed
    1. Clin Res Cardiol. 2010 Aug;99(8):499-506 - PubMed

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources